T1	Participants 28 113	Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention:
T2	Participants 272 297	acute coronary syndromes.
T3	Participants 529 662	patients on clopidogrel and high platelet reactivity undergoing percutaneous coronary intervention for acute coronary syndrome (ACS).
T4	Participants 672 689	Patients with ACS
T5	Participants 1131 1140	outcome).
T6	Participants 1141 1166	44 patients were enrolled
